Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

Presentation TCT 2018

Case #7: Bifurcation Stenting for Pulmonary Vein Stenosis

Presenter: Lee N. Benson, Eric Horlick, Zahid Amin, Makram R. Ebeid, Ioannis Iakovou, Michael J. Lim, Mark Osten, Harsimran Sachdeva Singh, Nathan W Taggart

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

L.A. McKeown

May 16, 2018

News Daily News

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Yael L. Maxwell

March 30, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

Advertisement

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Case #7: Bifurcation Stenting for Pulmonary Vein Stenosis

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Ticagrelor: Better Platelet Blockade Post-TAVR?

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content